Myriad Genetics Income Statement (2009-2026) | MYGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	189.40M	167.30M	160.80M	164.90M	179.30M	156.40M	177.80M	181.20M	183.50M	191.90M	196.60M	202.20M	211.50M	213.30M	210.60M	195.90M	213.10M	205.70M	209.80M	200.40M
Cost of Revenue (Quarter)	48.00M		-128.00M	48.00M	49.70M	50.40M	118.70M	59.20M	57.80M	57.60M	114.60M	69.40M	64.40M	63.50M	91.60M	61.70M	61.30M	71.00M	63.00M	62.80M
Gross Profit (Quarter)	141.40M	167.30M	288.80M	116.90M	129.60M	106.00M	59.10M	122.00M	125.70M	134.30M	82.00M	137.60M	147.10M	149.80M	150.90M	134.20M	151.80M	143.80M	146.80M	137.60M
Operating items
Research & Development (Quarter)	19.50M	18.80M	20.50M	21.20M	20.30M	20.50M	23.40M	22.50M	21.20M	24.00M	21.00M	24.90M	27.10M	28.50M	32.20M	27.50M	25.60M	28.20M	25.50M	27.10M
Selling, General & Administrative (Quarter)	135.20M	180.60M	75.60M	110.60M	127.10M	130.50M	-120.30M	151.70M	140.70M	136.10M	-144.80M	71.20M	72.10M	69.20M	64.00M	66.50M	66.80M	67.90M	55.60M	62.20M
Other Operating Expenses (Quarter)	55.50M	47.80M	107.80M	58.70M	49.70M	50.40M	124.90M	59.20M	135.30M	91.90M	115.60M	69.40M	84.40M	72.10M	93.70M	69.20M	388.60M	71.00M	71.40M	79.00M
Operating Expenses (Quarter)	210.20M	247.20M	203.90M	190.50M	197.10M	201.40M	28.00M	233.40M	297.20M	252.00M	-8.20M	165.50M	183.60M	169.80M	189.90M	163.20M	481.00M	167.10M	152.50M	168.30M
Operating Income (Quarter)	-20.80M	-79.90M	-43.10M	-25.60M	-17.80M	-45.00M	-52.20M	-52.20M	-113.70M	-60.10M	-31.40M	-27.90M	-36.50M	-20.00M	-39.00M	-29.00M	-329.20M	-23.30M	-5.70M	-30.70M
EBIT (Quarter)	-20.80M	-79.90M	-43.10M	-25.60M	-17.80M	-45.00M	-52.20M	-52.20M	-113.70M	-60.10M	-31.40M	-27.90M	-36.50M	-20.00M	-39.00M	-29.00M	-329.20M	-23.30M	-5.70M	-30.70M
Non-operating items
Interest & Investment Income (Quarter)	0.20M	0.20M	0.10M	0.10M	0.40M	1.10M	1.00M	0.70M	0.50M	0.60M	0.70M	0.60M	0.40M	0.40M	0.30M	0.30M	0.20M	0.50M	0.80M	0.70M
Other Non Operating Income (Quarter)	18.80M	120.60M			0.10M	0.50M		-0.60M	-2.40M	-0.70M	-0.70M	1.90M	-0.30M	-0.80M	0.30M	0.10M	-0.10M	0.40M	0.40M
Non Operating Income (Quarter)	18.80M	120.60M	5.50M		0.10M	0.80M	-0.60M	-0.40M	-2.40M	-1.10M	-0.90M	2.00M	-0.70M	-1.20M	0.30M	0.10M	-1.40M	0.40M	-8.30M	-3.40M
Net income details
EBT (Quarter)	-3.80M	39.80M	-43.50M	-26.40M	-17.90M	-44.20M	-52.10M	-52.60M	-116.10M	-61.20M	-32.30M	-25.90M	-37.20M	-21.20M	-39.10M	-29.40M	-330.60M	-26.20M	-8.90M	-34.10M
Tax Provisions (Quarter)	0.90M	15.20M	-35.90M	-5.90M	-3.80M	-9.10M	-9.80M	2.10M		0.10M	-1.10M	0.10M	-0.50M	0.90M	3.40M	-29.30M	-0.10M	1.20M	-1.00M
Profit After Tax (Quarter)	-4.70M	24.60M	-7.60M	-20.50M	-14.10M	-35.10M	-42.30M	-54.70M	-116.10M	-61.30M	-31.20M	-26.00M	-36.70M	-22.10M	-42.50M	-0.10M	-330.50M	-27.40M	-7.90M	-34.10M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-4.70M	24.60M	-7.60M	-20.50M	-14.10M	-35.10M	-42.30M	-54.70M	-116.10M	-61.30M	-31.20M	-26.00M	-36.70M	-22.10M	-42.50M	-0.10M	-330.50M	-27.40M	-7.90M	-34.10M
Consolidated Net Income (Quarter)	-4.70M	24.60M	-7.60M	-20.50M	-14.10M	-35.10M	-42.30M	-54.70M	-116.10M	-61.30M	-31.20M	-26.00M	-36.70M	-22.10M	-42.50M	-0.10M	-330.50M	-27.40M	-7.90M	-34.10M
Income towards Parent Company (Quarter)	-4.70M	24.60M	-7.60M	-20.50M	-14.10M	-35.10M	-42.30M	-54.70M	-116.10M	-61.30M	-31.20M	-26.00M	-36.70M	-22.10M	-42.50M	-0.10M	-330.50M	-27.40M	-7.90M	-34.10M
Net Income towards Common Stockholders (Quarter)	-4.70M	24.60M	-7.60M	-20.50M	-14.10M	-35.10M	-42.30M	-54.70M	-116.10M	-61.30M	-31.20M	-26.00M	-36.70M	-22.10M	-42.50M	-0.10M	-330.50M	-27.40M	-7.90M	-34.10M
Additional items
EPS (Basic) (Quarter)	-0.06	0.31	-0.10	-0.26	-0.18	-0.43	-0.52	-0.67	-1.42	-0.75	-0.34	-0.29	-0.41	-0.24	-0.47	0.00	-3.57	-0.29	-0.07	-0.36
EPS (Weighted Average and Diluted) (Quarter)	-0.06	0.30	-0.10	-0.26	-0.18	-0.43	-0.52	-0.67	-1.42	-0.75	-0.34	-0.29	-0.41	-0.24	-0.47	0.00	-3.57	-0.29	-0.07	-0.36
Shares Outstanding (Weighted Average) (Quarter)	77.20M	77.30M	78.00M	80.10M	80.30M	80.70M	80.60M	81.30M	81.70M	81.60M	82.80M	89.90M	90.30M	90.90M	90.60M	91.40M	92.50M	92.30M	92.60M	93.70M
Shares Outstanding (Diluted Average) (Quarter)	77.20M	81.50M	78.00M	80.10M	80.40M	80.40M	80.60M	81.30M	81.70M	81.60M	82.80M	89.90M	90.60M	90.90M	90.60M	91.40M	92.00M	93.10M	92.60M	93.70M
EBITDA (Quarter)	-20.80M	-79.90M	-43.10M	-25.60M	-17.80M	-45.00M	-52.20M	-52.20M	-113.70M	-60.10M	-31.40M	-27.90M	-36.50M	-20.00M	-39.00M	-29.00M	-329.20M	-23.30M	-5.70M	-30.70M
Interest Expenses (Quarter)	2.00M	1.10M	0.50M	0.90M	0.60M	0.80M	0.90M	0.50M	0.50M	1.00M	0.90M	0.50M	0.80M	0.80M	0.70M	0.80M	1.50M	3.80M	4.40M	4.10M
Tax Rate (Quarter)	-23.68%	38.19%	82.53%	22.35%	21.23%	20.59%	18.81%	-3.99%		-0.16%	3.41%	-0.39%	1.34%	-4.25%	-8.70%	99.66%	0.03%	-4.58%	11.24%

Research Tools

Myriad Genetics Income Statement (2009-2026) | MYGN

Create an account

Sign In

Reset Password